There are some on the other board who want to push the idea that IPIX will run out of money at some point down the road. However, what occurs to me is that the ongoing trials are wrapping up. B-UP is done, B-OM has completed enrollment and should be completed soon, P interim results are due in 6 weeks and the trial should be completed by year end and K is noted as a short trial as well. Interestingly, the costs incurred for these trials are coming to an end, so that FUD theory goes out the window. Also, there has been no talk of commencing PIII trials by IPIX on its own that I can recall. IMHO that means they are executing their plan to license/partner these drugs into commercialization.....are you ready?